AI for Pharma & Healthcare 2025

Cue Health and Pfizer Collaborate to Provide COVID Patients with Critical Health Info

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

From AI-powered EHRs to Real-Time Data...

Indonesia becomes the first country in the world to...

Beyond the Bedside: How Remote IT...

As American hospitals continue to grapple with an increasing...

MEDICAL FAIR THAILAND 2025 opens next...

MEDICAL FAIR THAILAND 2025, the 11th edition of Thailand’s...

Siemens, Prisma Health Value Partnership Boost...

Based in Greenville, USA, Siemens Healthineers, Prisma Health are...

Cue Health announced a new collaboration with Pfizer in the U.S. to raise awareness among individuals with certain underlying conditions about the risks of progressing to severe COVID-19 and the importance of seeking treatment if they test positive. Through Cue Care, Cue’s same-day, at-home, test-to-treatment platform, individuals will be able to use the Cue Health App to access educational resources like those available on Pfizer’s website, including information on risk factors for progression to severe illness from COVID-19, including hospitalisation or death.

This COVID-19 collaboration with Pfizer builds on recent initiatives launched by Cue to rapidly connect at-risk individuals with providers for care and, where appropriate, treatment.

Connected health solutions like the Cue platform offer potential for faster and more convenient access to care. This collaboration provides an opportunity to improve the test-to-treatment experience for patients and communities at high risk, which includes people 50 years of age and older.

Cue’s platform offers people support for each of those critical needs and is now integrating educational resources into Cue Care as part of this collaboration with Pfizer. Together, this actionable health information will help individuals make more informed decisions leading to better health outcomes.

Latest stories

Related stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »